Kintara Therapeutics (KTRA) PT Slashed to $3 at Dawson James on Dilution,
Tweet Send to a Friend
Dawson James analyst Jason H. Kolbert lowered the price target on Kintara Therapeutics, Inc (NASDAQ: KTRA) to $3.00 (from $5.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
